Articles

News, editorials, patient stories, and more.

This content is for informational purposes only and does not constitute medical advice. Always consult your doctor or a qualified healthcare provider before making any health decisions. Full Disclaimer

News

FDA Clears First BAFF/APRIL Blocker for Kidney Disease Linked to Autoimmunity

The FDA granted accelerated approval to atacicept (Trutakna) for primary IgA nephropathy, the first therapy to block two key immune signalin...

Read More — FDA Clears First BAFF/APRIL Blocker for Kidney Disease Linked to Autoimmunity »
Jul 7, 2026
News

A Decade-Long Hunt for What Actually Triggers Autoimmunity

A $4 million NIH grant will fund a 10-year study tracking the earliest biological triggers of lupus, rheumatoid arthritis, and related disea...

Read More — A Decade-Long Hunt for What Actually Triggers Autoimmunity »
Jul 6, 2026
News

Zoryve Psoriasis Cream Now Approved for Kids as Young as 2

The FDA expanded approval of Zoryve cream to children as young as 2 with plaque psoriasis, making it the first once-daily, steroid-free topi...

Read More — Zoryve Psoriasis Cream Now Approved for Kids as Young as 2 »
Jun 29, 2026
News

Funding a Closer Look at Lupus Brain Fog in Kids

Lupus Canada is funding a new study using a non-invasive brain-imaging technique to understand cognitive dysfunction in childhood-onset lupu...

Read More — Funding a Closer Look at Lupus Brain Fog in Kids »
Jun 29, 2026
News

A New Option for Thyroid Eye Disease, No Matter How Long You've Had It

The FDA approved Lumvoa, a new drug for thyroid eye disease that works whether a patient is in the active, painful early phase or has been l...

Read More — A New Option for Thyroid Eye Disease, No Matter How Long You've Had It »
Jun 26, 2026
News

A First-Ever Guideline for Kids With Axial Spondyloarthritis

The American College of Rheumatology released updated treatment guidelines for axial spondyloarthritis in adults, along with the first-ever...

Read More — A First-Ever Guideline for Kids With Axial Spondyloarthritis »
Jun 24, 2026
Best Magnesium Supplements for Hashimoto's Thyroiditis Blog

Best Magnesium Supplements for Hashimoto's Thyroiditis

Fatigue is one of the most persistent and frustrating symptoms for people with Hashimoto's thyroiditis, and it doesn't always resolve fully...

Read More — Best Magnesium Supplements for Hashimoto's Thyroiditis »
AutoimmuneArchive.com Staff · Jun 23, 2026
What Is DAS28 and Why Does My Rheumatologist Use It? Blog

What Is DAS28 and Why Does My Rheumatologist Use It?

Your rheumatologist calls out a number every visit, but rarely explains what it means. DAS28 measures joint tenderness, swelling, inflammati...

Read More — What Is DAS28 and Why Does My Rheumatologist Use It? »
Jun 22, 2026
News

A Path Opens for Gut-Focused Treatment in Younger IBD Patients

The FDA has accepted Takeda's application to expand intravenous Entyvio to children as young as 2 with moderate-to-severe ulcerative colitis...

Read More — A Path Opens for Gut-Focused Treatment in Younger IBD Patients »
Jun 9, 2026
News

A CAR-T for Lupus Clears the FDA

Imviva Biotech's CTA313, an off-the-shelf CAR-T cell therapy for lupus and other B-cell driven autoimmune diseases, has received FDA clearan...

Read More — A CAR-T for Lupus Clears the FDA »
Jun 9, 2026
News

Secukinumab Trial for Giant Cell Arteritis Brings Mixed but Useful Results

The Phase 3 GCAptAIN trial of secukinumab in giant cell arteritis did not meet its main goal of improving sustained remission, but patients...

Read More — Secukinumab Trial for Giant Cell Arteritis Brings Mixed but Useful Results »
John H. Stone, et al. · Jun 3, 2026
News

Experimental Antibody-Lowering Drug Shows Early Promise for Graves' Disease

Early Phase 1b data show Biohaven's BHV-1300 reduced disease-causing TSHR antibodies by more than 80 percent and normalized thyroid hormones...

Read More — Experimental Antibody-Lowering Drug Shows Early Promise for Graves' Disease »
Biohaven Ltd. · May 27, 2026